Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Non Operating Investment Income: 2020-2023

Historic Non Operating Investment Income for Insight Molecular Diagnostics (IMDX) over the last 4 years, with Dec 2023 value amounting to -$69,000.

  • Insight Molecular Diagnostics' Non Operating Investment Income fell 592.86% to -$69,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$61,000, marking a year-over-year increase of 87.05%. This contributed to the annual value of -$61,000 for FY2023, which is 87.05% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Non Operating Investment Income of -$69,000 as of Q4 2023, which was up 22.47% from -$89,000 recorded in Q3 2023.
  • Insight Molecular Diagnostics' 5-year Non Operating Investment Income high stood at $315,000 for Q4 2020, and its period low was -$330,000 during Q1 2022.
  • Over the past 3 years, Insight Molecular Diagnostics' median Non Operating Investment Income value was -$21,500 (recorded in 2021), while the average stood at -$25,250.
  • Data for Insight Molecular Diagnostics' Non Operating Investment Income shows a peak YoY increase of 981.25% (in 2021) and a maximum YoY decrease of 790.00% (in 2021) over the last 5 years.
  • Insight Molecular Diagnostics' Non Operating Investment Income (Quarterly) stood at $315,000 in 2020, then plummeted by 106.03% to -$19,000 in 2021, then surged by 173.68% to $14,000 in 2022, then crashed by 592.86% to -$69,000 in 2023.
  • Its Non Operating Investment Income stands at -$69,000 for Q4 2023, versus -$89,000 for Q3 2023 and -$24,000 for Q2 2023.